Zhu HQ - Search Results

1

[Detection of ABL kinase domain point mutations in chronic myeloid leukemia patients receiving imatinib treatment].

Ouyang Z, DU QF, Liu XL, Zhang S, Zhu HQ, Gong JM, Song LL, Ouyang LY, Liu Z. Ouyang Z, et al. Among authors: zhu hq. Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):704-6. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18504184 Chinese.

2

[Research advance on molecular genetics of CML blast crisis].

Zhu HQ, Zhang S, Liu XL. Zhu HQ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):217-21. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18315935 Review. Chinese.

3

The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia.

Du Q, Wang L, Zhu H, Zhang S, Xu L, Zheng W, Liu X. Du Q, et al. Med Oncol. 2010 Sep;27(3):673-9. doi: 10.1007/s12032-009-9267-z. Epub 2009 Aug 4. Med Oncol. 2010. PMID: 19653139

4

[Preliminary study of proteins related to blast crisis in chronic myeloid leukemia].

Zhu HQ, Liu XL, Li R, Du QF, Zhang S, Yao F, Liu Z. Zhu HQ, et al. Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):655-9. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021859 Chinese.

5

Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase fluorescence in situ hybridization and real-time quantitative reverse transcription PCR.

Zhu HQ, Liu XL, Song LL, Liu QF, Meng FY, Zhou SY. Zhu HQ, et al. Chin J Cancer. 2010 Feb;29(2):194-7. doi: 10.5732/cjc.009.10250. Chin J Cancer. 2010. PMID: 20109350 Free article.

6

High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.

Huang BT, Zeng QC, Yu J, Liu XL, Xiao Z, Zhu HQ. Huang BT, et al. Among authors: zhu hq. Med Oncol. 2012 Mar;29(1):251-9. doi: 10.1007/s12032-011-9820-4. Epub 2011 Jan 22. Med Oncol. 2012. PMID: 21258877 Clinical Trial.

7

[Effect of Decitabine on DKK1 Gene Demethylation in Leukemia Cells].

Liu FZ, He L, Wang JS, Zhang S, Zhu HQ. Liu FZ, et al. Among authors: zhu hq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):56-60. doi: 10.7534/j.issn.1009-2137.2016.01.011. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913394 Chinese.

8

Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Xu N, Li YL, Li X, Zhou X, Cao R, Li H, Li L, Lu ZY, Huang JX, Fan ZP, Huang F, Zhou HS, Zhang S, Liu Z, Zhu HQ, Liu QF, Liu XL. Xu N, et al. Among authors: zhu hq. J Hematol Oncol. 2016 Apr 18;9:40. doi: 10.1186/s13045-016-0270-5. J Hematol Oncol. 2016. PMID: 27090891 Free PMC article.

9

[Clinical Effect of Tyrosine Kinase Inhibitors in the Treatment of P230 Chronic Myeloid Leukemia].

Jiang YQ, Xu N, Liu XL, Wang JS, Yuan Z, Huang JX, Weng JY, Cao SY, Xiao SS, Zhu HQ. Jiang YQ, et al. Among authors: zhu hq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Dec;29(6):1752-1756. doi: 10.19746/j.cnki.issn.1009-2137.2021.06.010. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34893105 Chinese.

10

Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors.

Chen H, Wen Y, Zeng Y, Lin L, Sun B, Zhu H, He H, Wang X, Zou W, Zheng C, Zheng L, Huang J, Pang L, Huang J, Zhang Y, Lin H, Liu Z, Zhu W, Wang Q, Zhou X, Liu X, Qu H, Liu Z, Du X, Xu N. Chen H, et al. Oncol Ther. 2024 Mar;12(1):131-145. doi: 10.1007/s40487-023-00255-2. Epub 2023 Dec 16. Oncol Ther. 2024. PMID: 38104036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters